T2D
Clinical trials for T2D explained in plain language.
Never miss a new study
Get alerted when new T2D trials appear
Sign up with your email to follow new studies for T2D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug shield kidneys in obesity? new trial explores tirzepatide's potential
Disease control OngoingThis study looks at whether tirzepatide, a medication already used for diabetes and weight loss, can help slow or improve chronic kidney disease in people with obesity. About 140 participants will take the drug and have MRI scans to measure kidney fat and blood flow over 56 weeks…
Matched conditions: T2D
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Hidden liver risk in diabetes patients revealed
Knowledge-focused OngoingThis study aims to find out how many people with type 2 diabetes also have non-alcoholic fatty liver disease (NAFLD). Researchers will use a special ultrasound scan (FibroScan) to check the liver health of 385 adults with type 2 diabetes. The study does not test any new treatment…
Matched conditions: T2D
Phase: NA • Sponsor: Ziekenhuis Oost-Limburg • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:08 UTC